Antares Vision Group

Antares Vision Group is a technology company that develops and supplies an integrated ecosystem of hardware and software solutions for product quality inspection, serialization, and end-to-end supply chain traceability. Founded in 2007 in Castel Mella, near Brescia, Italy, the company has grown from an 18-person startup into a global group serving pharmaceutical manufacturers, medical device producers, hospitals, government authorities, and companies in the beverage, food, cosmetics, chemicals, and packaging industries. As of 2026, Antares Vision S.p.A. is a wholly owned subsidiary of Crane NXT, Co., integrated into its Detection & Traceability Technologies segment.

The company's core offering is branded under the DIAMIND ecosystem — an integrated platform connecting physical products with digital identities and operating across line, factory, warehouse, enterprise, and supply chain levels. DIAMIND combines inspection systems, track and trace software, and cloud-based data management, applying artificial intelligence and blockchain to guarantee product quality and traceability from raw materials through to the end consumer.

Track & Trace Solutions

• Provides serialization and traceability solutions for the pharmaceutical industry, supporting compliance with global regulatory requirements.
• Offers validated, preconfigured systems that access global reporting systems and support L1–L5 full-stack traceability.
• Addresses counterfeiting, diversion, and theft, and supports brand protection and patient engagement.
• More than 50% of the top 20 global pharmaceutical multinationals are reported as customers, along with several government authorities.
• In 2025, signed a multi-year agreement with the Ministry of Health of Guinea-Bissau to implement a National Pharmaceutical Traceability System and a Digital National Drug Catalog.

Inspection Machines

• Standalone automatic machines dedicated to parenteral products, incorporating visual inspection and Container Closure Integrity Testing (CCIT) technologies, including combinations of both in a single unit.
• Designed to meet regulatory requirements for product quality, integrity, and safety.
• In 2025, the group introduced AI-GO, an artificial intelligence system for visual inspection controls.

Inspection Systems

• Inline and integrated quality control systems for pharmaceutical products and medical devices on the production line.
• Covers inspection of finished packed products as well as in-process checks.
• Inspection types include color, shape, size, integrity, mix-up detection, pattern matching, OCR/OCV, and code reading.

DIAMIND Factory

• A data intelligence platform for plant management, aimed at improving line efficiency and production quality.
• Supports production planning and agile decision-making based on real-time data.
• Designed to maximize operational efficiency and productivity across manufacturing facilities.

Supply Chain Transparency

• End-to-end digital supply chain visibility solutions supporting regulatory compliance and partner connectivity across global markets.
• Covers serialization, traceability, and reporting requirements at the supply chain level.
• In 2025, DIAMIND Connect was launched to extend end-to-end product monitoring to the food, beverage, cosmetics, textile, and chemical industries, with support for Digital Product Passport requirements and documentation of production efficiency and sustainability.

Digital Healthcare

• Offers a medication management platform as part of its digital healthcare portfolio, targeting hospitals and healthcare institutions.
• In early 2026, launched the Antares Vision Biobanking Platform (AVBP), a technology platform designed to digitize, standardize, and automate core operations of modern biobanks.

Industries Served

• Life sciences: pharmaceuticals, medical devices, and hospitals
• Beverage, food, cosmetics, chemicals, and packaging
• Government authorities and institutions requiring supply chain monitoring and product authentication

Notable Developments and Partnerships

• Acquired a stake in Genuine Way in 2025 to strengthen its business-to-consumer traceability offering.
• Entered a strategic agreement with a US-based multinational in the FMCG sector for the development of a global serialization and traceability platform.
• Has maintained a presence in the African pharmaceutical sector for over a decade, with contributions to traceability, quality, and safety in that region.
• Participates in major industry events including Interphex, Interpack, PDA Week, and Pharmintech.

Antares Vision Group operates across multiple geographies and supports its customers through a combination of hardware engineering, software development, and services, with solutions available in multiple languages and deployable across diverse regulatory environments worldwide.